日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer

循环肿瘤DNA中的致病性基因组改变可预测转移性去势抵抗性前列腺癌患者的总生存期

Halabi, Susan; Guo, Siyuan; Luo, Bin; Yu, Chenxi; Knutson, Todd P; Kobilka, Anna; Lyman, Jacqueline; Beltran, Himisha; Antonarakis, Emmanuel S; Galsky, Matthew D; Rosenberg, Jonathan E; Ryan, Charles J; Small, Eric J; Kelly, W Kevin; Morris, Michael J; Page, David; Dehm, Scott M; Armstrong, Andrew J

Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer

FOR46 (FG-3246) 是一种靶向 CD46 的免疫调节抗体药物偶联物,用于治疗转移性去势抵抗性前列腺癌患者,这是一项 I 期首次人体研究。

Aggarwal, Rahul R; Vuky, Jacqueline; VanderWeele, David; Rettig, Matthew; Heath, Elisabeth I; Quigley, David; Huang, Jiaoti; Chumber, Arun; Cheung, Alexander; Foye, Adam; Leung, Stanley; Abbey, Jill; Dorr, Andrew; Nasoff, Marc; Hunter, John; Wang, Steven; Flavell, Robert R; Fong, Lawrence; Liu, Bin; Small, Eric J

Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer

转移性激素敏感性前列腺癌早期前列腺特异性抗原反应的有利预测

Roy, Soumyajit; Sun, Yilun; Hussain, Maha; Chi, Kim N; Fizazi, Karim; Davis, Ian D; Halabi, Susan; Agarwal, Neeraj; Chowdhury, Simon; Tombal, Bertrand; Morgan, Scott C; Malone, Shawn; Barata, Pedro C; Ong, Michael; Wallis, Christopher J D; Berlin, Alejandro; Swami, Umang; Kishan, Amar U; Jia, Angela Y; Zaorsky, Nicholas G; Garcia, Jorge A; Mendiratta, Prateek; Brown, Jason R; Subhash, Vinod V; Stockler, Martin R; Thomas, Hayley; McKay, Rana R; Small, Eric J; Shore, Neal D; Saad, Fred; Sweeney, Christopher J; Spratt, Daniel E

PROX1 is an early driver of lineage plasticity in prostate cancer.

PROX1 是前列腺癌谱系可塑性的早期驱动因素

Duan Zhi, Shi Mingchen, Kumaraswamy Anbarasu, Lin Dong, Khokhani Dhruv, Wang Yong, Zhang Chao, Flores Diana, Rodansky Eva, Swaim Olivia A, Storck William K, Beck Hannah N, Patel Radhika A, Sayar Erolcan, Hanratty Brian P, Xue Hui, Dong Xin, Maylin Zoe R, Wan Rensheng, Quigley David A, Sjöström Martin, Hu Ya-Mei, Zhao Faming, Xia Zheng, Cheng Siyuan, Yu Xiuping, Feng Felix Y, Zhang Li, Aggarwal Rahul, Small Eric J, Ravikumar Visweswaran, Rao Arvind, Bedi Karan, Lee John K, Morrissey Colm, Coleman Ilsa, Nelson Peter S, Corey Eva, Udager Aaron M, Rebernick Ryan J, Cieslik Marcin P, Chinnaiyan Arul M, Yates Joel A, Haffner Michael C, Wang Yuzhuo, Alumkal Joshi J

Statin Use in Patients With Advanced Prostate Cancer in the TITAN and SPARTAN Trials

TITAN 和 SPARTAN 试验中他汀类药物在晚期前列腺癌患者中的应用

Roy, Soumyajit; Ozay, Zeynep Irem; Guha, Avirup; Sun, Yilun; Chi, Kim N; Morgan, Scott C; Malone, Shawn; Wallis, Christopher J D; Brown, Jason R; Barata, Pedro C; Kishan, Amar U; Jia, Angela Y; Zaorsky, Nicholas G; Swami, Umang; Chowdhury, Simon; Small, Eric J; Spratt, Daniel E; Saad, Fred; Agarwal, Neeraj

Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer.

转录组分析揭示了致命性前列腺癌中恩扎卢胺极度无反应的机制

Kumaraswamy Anbarasu, Hu Ya-Mei, Yates Joel A, Zhang Chao, Rodansky Eva, Khokhani Dhruv, Flores Diana, Duan Zhi, Zhang Yi, Tabatabaei Shaadi, Slottke Rachel, Ye Shangyuan, Lara Primo, Foye Adam, Ryan Charles J, Quigley David A, Huang Jiaoti, Aggarwal Rahul, Reiter Robert E, Wicha Max S, Beer Tomasz M, Rettig Matthew, Gleave Martin, Evans Christopher P, Witte Owen N, Stuart Joshua M, Thomas George V, Feng Felix Y, Small Eric J, Xia Zheng, Alumkal Joshi J

Racial variation in the advanced prostate cancer genome

晚期前列腺癌基因组的种族差异

Feng, Emily M; Vo-Phamhi, Jenny; Subramanian, Aishwarya N; Dias, Mikhail; Foye, Adam; Vinson, Jake; Hong, Julian C; Freedland, Stephen J; Alumkal, Joshi J; Beltran, Himisha; Morrissey, Colm; Nelson, Peter S; Chinnaiyan, Arul M; Aggarwal, Rahul; Small, Eric J; Quigley, David A; Sjöström, Martin; Zhao, Shuang G; Chen, William S

Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancer

转移性去势抵抗性前列腺癌的不良预后基因表达模式

Sharifi, Marina N; Feng, Eric; Rydzewski, Nicholas R; Taylor, Amy K; Sperger, Jamie M; Shi, Yue; Helzer, Kyle T; Bootsma, Matthew L; Carreno, Viridiana; Chang, Alex H; Nunamaker, Luke A; Blitzer, Grace C; Shang, Tianfu Andy; Subramanian, Aishwarya; Bjartell, Anders; Josefsson, Andreas; Wikström, Pernilla; Feng, Emily; Kohli, Manish; Yang, Rendong; Dehm, Scott M; Small, Eric J; Aggarwal, Rahul; Quigley, David A; Lang, Joshua M; Zhao, Shuang G; Sjöström, Martin

Utility of metastasis-directed radiotherapy with and without hormonal therapy in management of oligometastatic prostate cancer

转移灶定向放射治疗联合或不联合激素治疗在寡转移性前列腺癌治疗中的应用价值

Chen, William S; Tuchayi, Abuzar Moradi; Sabbagh, Ali; Kim, Inkyu; Porter, Evan; Ashraf-Ganjouei, Amir; Li, Yun Rose; Witztum, Alon; Rajagopal, Abhejit; Seyedin, Steven N; Juarez, Roxanna; Carroll, Peter R; Feng, Felix Y; Small, Eric J; Hope, Thomas A; Hong, Julian C

A plain language summary of the results from the MAGNITUDE study assessing how effective and how safe niraparib and abiraterone acetate with prednisone is in patients with metastatic castration-resistant prostate cancer

MAGNITUDE 研究结果的简明语言摘要,该研究评估了尼拉帕尼和醋酸阿比特龙联合泼尼松治疗转移性去势抵抗性前列腺癌患者的疗效和安全性。

Chi, Kim N; Rathkopf, Dana; Smith, Matthew R; Efstathiou, Eleni; Attard, Gerhardt; Olmos, David; Lee, Ji Youl; Small, Eric J; Pereira de Santana Gomes, Andrea J; Roubaud, Guilhem; Saad, Marniza; Zurawski, Bogdan; Sakalo, Valerii; Mason, Gary E; Francis, Peter; Wang, George; Wu, Daphne; Diorio, Brooke; Lopez-Gitlitz, Angela; Sandhu, Shahneen